Teclistamab,Daratumumab,Pomalidomide,Lenalidomide,Bortezomib,Nirogacestat
Genmab,Janssen,springworks therapeutics,Takeda,bms
['majestec-2', 'dara+', 'teclistamab', 'majestec,(-majestec-1),(-majestec1),(-majestec 1),(-majestec-3),(-majestec3),(-majestec 3),(-majestec-i),(-majestec i),(-majesteci)']
flourishing time for bispecifics in mm! efficacy results of majestec-2 trial (teclistamab+dara+len) in mm after 1-3 lines of therapy #ash22 
Oncology / Hematology and SCT Clinical Pharmacist @NGHAnews | Alum @UICPharm @BrighamWomens